BAFNAPH
Start SIP
Invest Now
Start SIP in BAFNAPH
Bafna Pharmaceuticals live price: ₹106.99. It opened at ₹113 vs previous close ₹112; intraday high/low: ₹117/₹107. The 50 & 200 DMA stand at ₹122.19/₹121.19.
Bafna Pharmaceuticals Performance
- Low
- ₹107
- High
- ₹117
- 52 Week Low
- ₹71
- 52 Week High
- ₹202
- Open Price₹113
- Previous Close₹112
- Volume7,558
- 50 DMA₹122.19
- 100 DMA₹127.26
- 200 DMA₹121.19
Investment Returns
- Over 1 Month -7.77%
- Over 3 Month -23.73%
- Over 6 Month + 8.03%
- Over 1 Year + 30.71%
Smart Investing Starts Here Start SIP with Bafna Pharmaceuticals for Steady Growth!
Bafna Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 26.2
- PEG Ratio
- 0.2
- Market Cap Cr
- 253
- P/B Ratio
- 2.7
- Average True Range
- 6.34
- EPS
- 4.84
- Dividend Yield
- 0
- MACD Signal
- -4.83
- RSI
- 38.05
- MFI
- 31.27
Bafna Pharmaceuticals Financials
Bafna Pharmaceuticals Technicals
EMA & SMA
Current Price
₹106.99
-5.2
(-4.63%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹112.85
- 50 Day
- ₹122.19
- 100 Day
- ₹127.26
- 200 Day
- ₹121.19
Resistance and Support
110.19
- R3 124.21
- R2 120.60
- R1 113.80
- S1 103.39
- S2 99.78
- S3 92.98
Bafna Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-11 | Quarterly Results | |
| 2025-11-11 | Quarterly Results | |
| 2025-08-12 | Quarterly Results | |
| 2025-05-26 | Audited Results | |
| 2025-02-06 | Quarterly Results |
Bafna Pharmaceuticals F&O
About Bafna Pharmaceuticals
- NSE Symbol
- BAFNAPH
- BSE Symbol
- 532989
- ISIN
- INE878I01022
Similar Stocks to Bafna Pharmaceuticals
Bafna Pharmaceuticals FAQs
Bafna Pharmaceuticals share price is ₹106 As on 09 March, 2026 | 23:29
The Market Cap of Bafna Pharmaceuticals is ₹253.1 Cr As on 09 March, 2026 | 23:29
The P/E ratio of Bafna Pharmaceuticals is 26.2 As on 09 March, 2026 | 23:29
The PB ratio of Bafna Pharmaceuticals is 2.7 As on 09 March, 2026 | 23:29
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.